Cart
sales@molnova.com
1-(3-chloropyridin-2-yl)piperazine dihydrochloride
CAS No. 1193389-39-7
1-(3-chloropyridin-2-yl)piperazine dihydrochloride ( —— )
Catalog No. M28387 CAS No. 1193389-39-7
1-(3-chloropyridin-2-yl)piperazine dihydrochloride is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 68 | Get Quote |
|
| 25MG | 115 | Get Quote |
|
| 50MG | 173 | Get Quote |
|
| 100MG | 258 | Get Quote |
|
| 200MG | 388 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1-(3-chloropyridin-2-yl)piperazine dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief Description1-(3-chloropyridin-2-yl)piperazine dihydrochloride is a chemical compound.
-
Description1-(3-chloropyridin-2-yl)piperazine dihydrochloride is a chemical compound.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFLAP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1193389-39-7
-
Formula Weight270.6
-
Molecular FormulaC9H14Cl3N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.Clc1cccnc1N1CCNCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hutchinson JH, et al. 5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103). J Med Chem. 2009 Oct 8;52(19):5803-15.
molnova catalog
related products
-
AS2717638
AS2717638 is an orally active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist (IC50: 38 nM for hLPA5).
-
2'-Deoxyuridine 5'-m...
2'-Deoxyuridine 5'-monophosphate (dUMP) is used by the enzyme thymidylate synthetase (TS) for the de novo production of dTMP. dUMP is used as the reference substrate in studies of dUMP analogues in potential chemotherapy applications.
-
Golgicide A
Golgicide A is a potent and rapidly reversible GBF1 inhibitor.
